17410413 24091601 17943697 23685641 22619024 17197893 29032459 31671410 29678704 34017065 18226735 16497445 26743473 20717480 25534889 22863387 25248587 19945030 29344907 27346850 34800730 26122495 30058871 24601912 23040742 18350381 29535093 2251725 - Search Results

Year	Number of Results
2006	1
2007	4
2008	1
2009	3
2010	3
2012	5
2013	2
2014	4
2015	6
2016	5
2018	5
2019	1
2021	2
2022	0

1

Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease.

Iino K, Oki Y, Matsushita F, Yamashita M, Hayashi C, Miura K, Nishizawa S, Nakamura H. Iino K, et al. Pituitary. 2007;10(1):35-45. doi: 10.1007/s11102-007-0010-5. Pituitary. 2007. PMID: 17410413

2

The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas.

Mete O, Hayhurst C, Alahmadi H, Monsalves E, Gucer H, Gentili F, Ezzat S, Asa SL, Zadeh G. Mete O, et al. Endocr Pathol. 2013 Dec;24(4):191-8. doi: 10.1007/s12022-013-9270-y. Endocr Pathol. 2013. PMID: 24091601

3

Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence.

Psaras T, Honegger J, Buslei R, Saeger W, Klein D, Capper D, Meyermann R, Mittelbronn M. Psaras T, et al. Exp Clin Endocrinol Diabetes. 2007 Oct;115(9):610-5. doi: 10.1055/s-2007-984437. Exp Clin Endocrinol Diabetes. 2007. PMID: 17943697

4

A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas.

Jahangiri A, Wagner JR, Pekmezci M, Hiniker A, Chang EF, Kunwar S, Blevins L, Aghi MK. Jahangiri A, et al. Neurosurgery. 2013 Jul;73(1):8-17; discussion 17-8. doi: 10.1227/01.neu.0000429858.96652.1e. Neurosurgery. 2013. PMID: 23685641

5

Clinical features of silent corticotroph adenomas.

Alahmadi H, Lee D, Wilson JR, Hayhurst C, Mete O, Gentili F, Asa SL, Zadeh G. Alahmadi H, et al. Acta Neurochir (Wien). 2012 Aug;154(8):1493-8. doi: 10.1007/s00701-012-1378-1. Epub 2012 May 24. Acta Neurochir (Wien). 2012. PMID: 22619024

6

Silent corticotroph cell pituitary adenoma in a struma ovarii.

Waugh MS, Soler AP, Robboy SJ. Waugh MS, et al. Int J Gynecol Pathol. 2007 Jan;26(1):26-9. doi: 10.1097/01.pgp.0000228139.94339.e0. Int J Gynecol Pathol. 2007. PMID: 17197893

7

Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.

Langlois F, Lim DST, Yedinak CG, Cetas I, McCartney S, Cetas J, Dogan A, Fleseriu M. Langlois F, et al. Pituitary. 2018 Feb;21(1):32-40. doi: 10.1007/s11102-017-0844-4. Pituitary. 2018. PMID: 29032459 Review.

8

Postoperative expression of Cushing disease in a young male: metamorphosis of silent corticotroph adenoma?

Jahan S, Hasanat MA, Mahmood T, Morshed S, Haq R, Fariduddin M. Jahan S, et al. Endocrinol Diabetes Metab Case Rep. 2019 Oct 1;2019:19-0046. doi: 10.1530/EDM-19-0046. Online ahead of print. Endocrinol Diabetes Metab Case Rep. 2019. PMID: 31671410 Free PMC article.

9

Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.

Kim D, Ku CR, Park SH, Moon JH, Kim EH, Kim SH, Lee EJ. Kim D, et al. World Neurosurg. 2018 Jul;115:e464-e471. doi: 10.1016/j.wneu.2018.04.070. Epub 2018 Apr 17. World Neurosurg. 2018. PMID: 29678704

10

Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.

Asa SL, Mete O, Cusimano MD, McCutcheon IE, Perry A, Yamada S, Nishioka H, Casar-Borota O, Uccella S, La Rosa S, Grossman AB, Ezzat S; Attendees of the 15th Meeting of the International Pituitary Pathology Club, Istanbul October 2019. Asa SL, et al. Mod Pathol. 2021 Sep;34(9):1634-1650. doi: 10.1038/s41379-021-00820-y. Epub 2021 May 21. Mod Pathol. 2021. PMID: 34017065 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results